Neuberger Berman Group
ASMB icon

Neuberger Berman Group’s Assembly Biosciences ASMB Stock Holding History

Neuberger Berman Group’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,083
Closed -$256K – 1549
2019
Q1 		$256K Buy
+1,083
New +$274K ﹤0.01% 1413
2018
Q1 		– Sell
-458
Closed -$249K – 1674
2017
Q4 		$249K Buy
+458
New +$207K ﹤0.01% 1621

Other funds holding ASMB

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Neuberger Berman Group's ASMB Position: Q2 2019 in Review

Neuberger Berman Group sold out of Assembly Biosciences (ASMB) in Q2 2019, closing a stake of 1,083 shares — an estimated $256K sold.

Neuberger Berman Group first reported a position in ASMB in Q4 2017 and held it in 2 quarters. The position peaked at $256K in Q1 2019. 106 funds tracked by Wall St. Rank hold ASMB as of Q2 2019.

  • Neuberger Berman Group reported no remaining Assembly Biosciences position as of Q2 2019 after selling out during the quarter.
  • Neuberger Berman Group sold 1,083 Assembly Biosciences shares in Q2 2019, an estimated $256K.
  • Neuberger Berman Group first reported a position in Assembly Biosciences in Q4 2017 and held it in 2 quarters.
  • Neuberger Berman Group's Assembly Biosciences position peaked at $256K in Q1 2019.
  • 106 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2019.

Based on Neuberger Berman Group's 13F filing for Q2 2019, filed 13 Aug 2019.